Patent classifications
C12N2840/002
Methods and compositions to prevent microbial infection
Methods and compositions are provided for durably influencing microbiological ecosystems (microbiomes) in a subject in order to prevent infection and reduce recurrence of infection by microorganisms. In some embodiments, compositions and methods are provided for the creation and use of molecularly-modified bacterial strains with the potential to prevent a variety of microorganism infections.
Target gene expression control system comprising dxCas9 and CRP derivative and preparation method therefor
Disclosed are a plasmid comprising dxCas9 and a CRP derivative for controlling the expression of a target gene, a recombinant strain transformed with the plasmid, a preparation method therefor, a target gene control system, and a method for controlling the expression of a target gene, wherein the plasmid, recombinant strain, and expression control system according to the present invention can improve the production of high-value-added substances by construction of a system for simultaneously and multiply controlling the expression of target genes.
BLUE LIGHT-INDUCIBLE SYSTEM FOR GENE EXPRESSION
The present invention provides methods for light-dependent gene regulation using a light-responsive DNA-binding protein. Also provided are related nucleic acid molecules, and protein molecules, such as those encoding or comprising the light-responsive DNA-binding protein or DNA-binding sites recognizing the light-responsive DNA-binding protein. Kits using the present light-dependent gene regulation system are further provided by the present invention.
DNA RECOMBINASE CIRCUITS FOR LOGICAL CONTROL OF GENE EXPRESSION
The invention provides, inter alia, recombinase-based systems that provide for integrated logic and memory in living cells such as mammalian cells. The nucleic acid cassettes, switches, and systems described herein allow for control of gene expression or gene regulation. The invention also provides nucleic acid-based switches for adopted T-cell therapy.
Reduction of Tobacco-Specific Nitrosamines Using Genetic Modification to Elevate Production of Native Antioxidants in Tobacco
Cured tobacco having a lower concentration of tobacco specific nitrosamines, can be produced from a transgenic tobacco plant having a heterologous nucleotide sequence encoding a polypeptide that catalyzes production of active oxygen species. The heterologous nucleotide sequence is operably coupled to a regulatory nucleotide sequence that directs expression of the polypeptide. The regulatory nucleotide sequence can include constitutive and/or inducible promoter elements.
Synthetic transcriptional control elements and methods of generating and using such elements
Provided herein are nucleic acid constructs that contain a synthetic control element that includes a cis-regulator of translation, and an adapter translation-coupled regulator of transcription. Further provided herein are nucleic acid constructs that contain nucleic acid sequences under the control of the synthetic control elements. Also provided are compositions and methods related to the nucleic acid constructs.
APTAMERS AND SMALL MOLECULE LIGANDS
The present disclosure provides aptamers that bind to certain small molecules. Also contemplated are riboswitches and polynucleotide cassettes for regulating the expression of a target gene, wherein the polynucleotide cassettes comprise the aptamers disclosed herein. Further provided are small molecules that bind to the aptamers disclosed herein and are modulators of target gene expression where the target gene contains a riboswitch comprising an aptamer described herein.
Reduction of tobacco-specific nitrosamines using genetic modification to elevate production of native antioxidants in tobacco
Cured tobacco having a lower concentration of tobacco specific nitrosamines, can be produced from a transgenic tobacco plant having a heterologous nucleotide sequence encoding a polypeptide that catalyzes production of active oxygen species. The heterologous nucleotide sequence is operably coupled to a regulatory nucleotide sequence that directs expression of the polypeptide. The regulatory nucleotide sequence can include constitutive and/or inducible promoter elements.
CHIMERIC REPRESSORS AND METHODS OF USING THE SAME
Embodiments provided for herein relate to a CRO repressor system, compositions comprising the same, and methods of using the same. In some embodiments, the repressor system comprises at least one promoter region operably connected to a nucleotide sequence encoding for a CRO repressor protein. In some embodiments, the sequence encoding for a CRO repressor protein is operably connected to a nuclear localization signal. In some embodiments, a polypeptide is provided that is encoded by a polynucleotide as provided for herein.
BIOCONTROL
Provided is an arthropod male germline gene expression system suitable for conditional expression of an effector gene in an Arthropod male germline. The system comprises a first expression unit comprising an effector gene and a promoter therefor operably linked thereto; and a second expression unit. Said second unit comprises a coding sequence for a transcription factor and an upstream regulatory element operably linked thereto, the transcription factor being capable of acting upon the promoter in the first expression unit to drive expression of the effector gene. The upstream regulatory element includes a promoter for the transcription factor; and a 5 UTR adjacent a start site for the transcription factor coding sequence. The upstream regulatory element driving sufficient expression of the transcription factor such that the transcription factor protein in turn drives transcription of the effector gene before meiosis. Also provided are uses of the system for instance in methods of biocontrol and quality control.